The Vaccine Preventable Diseases programme of ECDC has set up a working group to provide guidance to the European Union Member States on the potential introduction of varicella vaccination.
A vaccine is available which protects against the varicella virus; however policies on vaccine use vary across the EU. Varicella vaccination for all children is only recommended at national level in five countries (for the list of those countries see the ECDC vaccine scheduler). In most countries vaccination is available for adolescents without history of varicella and for the people who have higher risk of coming into contact with the varicella virus, like healthcare workers.
This EUVAC.NET report provides an overview of the surveillance systems in place for varicella and herpes zoster as of November 2010, and analyses possible and future strategies for varicella and zoster surveillance in Europe.
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).
This surveillance report was prepared by EUVAC.net, which is a European surveillance network for vaccine-preventable diseases. The network collects data on surveillance systems and selected epidemiological characteristics of vaccine preventable diseases in the EU and other participating countries. It is jointly funded by ECDC and the Statens Serum Institut (Denmark).